Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 87131 · Class III · American National Red Cross, Penn Jersey Region
Key facts
| Event ID | 87131 |
|---|---|
| Recall numbers | B-0244-2021, B-0245-2021, B-0246-2021, B-0247-2021 |
| Recalling firm | American National Red Cross, Penn Jersey Region |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced, Blood and Blood Products for Reprocessing, Plasma Frozen, Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, collected from a donor with a history of high risk behavior, were distributed. |
| Initiation date | Nov 2, 2020 |
| Report date | Mar 3, 2021 |
| Termination date | Feb 19, 2021 |
| City | Philadelphia |
| State | PA |
| Country | United States |
| FEI number | 2573021 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: